A mum who helped change the law on medical cannabis has commissioned a Nottinghamshire company to produce an organic, pharmaceutical-grade CBD product.
Charlotte Caldwell says cannabis oil reduced the number of life-threatening epileptic seizures suffered by her son Billy, 13, but she had the item confiscated at Heathrow Airport. The situation convinced Home Secretary Sajid Javid to legalise its use in some cases.
Now Ms Caldwell wants Nottingham-based The Cannabis Oil Company (TCOC), which is in a joint venture with pharmaceutical supplier IPS Specials, to create an off-the-shelf product which can treat people like her son.
The campaigner, from County Tyrone in Northern Ireland, said: “This is about improving the financial wellbeing of our NHS and the wellbeing of the people of our nation who believe in or have experienced the benefits of CBD (cannabidiol).
“I am no clinician, but having spent virtually every waking hour for a decade or more interacting with experts and studying medicinal cannabis and CBD with the key objective of improving Bill’s quality of life – and at times averting his death – I have gained a level of expertise that’s highly relevant to other families similarly affected.
“What I’ve learnt in taking and answering hundreds of messages a week is that few of them truly understand CBD and medicinal cannabis, and that means many are being hoodwinked into buying products of dire quality, and often with no CBD content at all.
“TCOC has listened and are acting upon my vision. They are a small business with a social conscience, run by good people who have a genuine concern and frustration for the thousands who depend upon cannabis-based medicinal products (CBMPs) to help them through mental and physical health conditions.
“TCOC has appointed a highly-qualified board of advisers, including NHS specialist clinician, researchers and academics, an important factor in my decision.”
Ms Caldwell, who is speaking at The Women, CBD and Medical Conference today (May 18), has joined the company as a special advisor.
Focusing primarily on the online market, the firm is now crowdfunding for Â£500,000 and says it is on track as it attempts to expand into a market forecast to be worth roughly Â£1.5 billion by next year.
Their aim is to produce pharma-standard products which will be available through 5,500 pharmacies.
Freddie Reid, co-founder of the business, said: “CBD is a misunderstood product in the UK, but has years of evidence of its efficacy behind it in many advanced healthcare nations. CBD is available now.
“Medicinal cannabis, once through clinical trials, will bring a second wave of opportunity, and those investing in CBD now are mindful that the UK medicinal community will accept cannabis-derived medicinal products on completion of trials, and that CBD producers will be in pole position to shift or expand into medicinal cannabis production.
“CBD is in its infancy; the more we learn, the more the potential becomes apparent.”
To receive one WhatsApp message a day with the main headlines, as well as breaking news alerts, text NEWS to 07790 586202.
Then add the number to your phone contacts book as ‘Nottingham Post’.
Your phone number won’t be shared with other members of the group.